Fisher Patrick, who serves as the President of Global Limb Recon at Orthofix Medical Inc., has sold 150 shares of the company’s common stock. This transaction occurred on November 2, 2026, and was reported in the latest SEC filing on November 4, 2026.

This sale is significant as it highlights ongoing management activity within Orthofix Medical, a company that operates in the surgical and medical instruments industry. Such transactions can indicate the confidence or strategy of executives regarding the company's future performance.

Background

Orthofix Medical Inc. is a company involved in the surgical and medical instruments sector. The company is based in Lewisville, Texas, and operates under the ticker symbol OFIX. The recent filing history includes multiple Form 4 submissions, indicating regular reporting of insider transactions.

What the Filing Says

According to the SEC filing (accession number 0001193125-26-447190), the sale of 150 shares was executed at a price of $9.07 per share. Following this transaction, Patrick retains ownership of 50,769 shares, which includes 36,028 previously reported restricted stock units. The filing notes, "The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026."

Impact

This sale may affect perceptions of Orthofix Medical among investors and analysts, as insider transactions can signal confidence or caution regarding the company’s performance. Additionally, it may have implications for the surgical and medical instruments industry, as other executives may follow suit in similar transactions.

What's Next

The filing does not say what happens next.